Proteros biostructures GmbH, situated in Munich, has expanded its epigenetic medicine collaboration with AstraZeneca. This multi-year extension builds on a...
Read moreAbbVie, located in Chicago, and Cugene, based in Waltham, Massachusetts, have formed a partnership to research medicines for autoimmune diseases...
Read moreFor the first time in the week starting May 16th, Japan's three major pharmaceutical trade associations joined forces to call...
Read moreWith high hopes, Eli Lilly's Mounjaro (tirzepatide) was promoted to the big leagues in the week ending May 14, when...
Read moreDELIVER is the world's largest study of heart failure with intact ejection fraction. The DELIVER phase 3 trial produced favourable...
Read moreThe US Food and Drug Administration recently announced that the Johnson & Johnson/Janssen COVID-19 vaccine's urgent use permit will be...
Read moreCharles River Laboratories International, Inc. and Valo Health, Inc have launched Logica , an artificial intelligence (AI) powered drug solution...
Read moreAstraZeneca announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub....
Read moreAccording to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19...
Read moreBristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November....
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.